MicroRNA Let‐7b‐5p Targets IGF1R to Inhibit the Progression of Hepatocellular Carcinoma Through the AKT / mTOR Pathway
Cancer Medicine · 2025
DOI: 10.1002/cam4.71000 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Jiaojiao Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Anhui University of Science & Technology (Huainan First People's Hospital), Huainan, China. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Hepatocellular, Liver Neoplasms, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2023 Specialized Medical Cultivation Project of Anhui University Of Science & Technology.
Abstract (Originalsprache)
Background
Hepatocellular carcinoma (HCC) remains a major global health burden, with microRNA Let‐7b‐5p (Let‐7b‐5p) emerging as a potential tumor suppressor. However, its precise role and molecular mechanisms in HCC progression remain unclear, necessitating further investigation.
Methods
We assessed Let‐7b‐5p expression in HCC versus normal hepatocytes via qRT‐PCR and employed functional assays (clone formation, EdU, scratch, Transwell, apoptosis) to examine its effects on proliferation, migration, and cell death. Mechanistic studies combined bioinformatics, Western blotting, and IHC to validate IGF1R as a target and assess AKT/mTOR pathway activity.
Results
Let‐7b‐5p was significantly downregulated in HCC cells, and its overexpression suppressed proliferation, migration, and enhanced apoptosis. Mechanistically, Let‐7b‐5p directly targeted IGF1R, leading to reduced phosphorylation of AKT/mTOR, indicating pathway inhibition.
Conclusions
Our findings establish Let‐7b‐5p as a critical regulator of HCC progression via IGF1R‐mediated AKT/mTOR suppression, offering a potential therapeutic strategy for HCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Anhui University of Science & Technology (Huainan First People's Hospital), Huainan, China.
- Medical College, Anhui University of Science & Technology, Huainan, China.
- Huainan Maternity and Child Health Hospital, Huainan, China.
- Central and Clinical Laboratory, The Affiliated Huaian Hospital of Xuzhou Medical University and Huaian Second Hospital, Huaian, China.
ORCID-Profile: Jiaojiao Liang
Förderung
- 2023 Specialized Medical Cultivation Project of Anhui University Of Science & Technology
Zitieren
APA
Liang, J., Li, A., Chen, J., Cao, N., Zhu, T., Cai, R., Zhou, S., Liang, Y., & Tang, X. (2025). MicroRNA Let‐7b‐5p Targets IGF1R to Inhibit the Progression of Hepatocellular Carcinoma Through the AKT / mTOR Pathway. Cancer Medicine. https://doi.org/10.1002/cam4.71000
Vancouver
Liang J, Li A, Chen J, Cao N, Zhu T, Cai R, et al. MicroRNA Let‐7b‐5p Targets IGF1R to Inhibit the Progression of Hepatocellular Carcinoma Through the AKT / mTOR Pathway. Cancer Medicine. 2025. doi:10.1002/cam4.71000
BibTeX
@article{Liang2025,
author = {Liang, Jiaojiao and Li, Amin and Chen, Jun and Cao, Niandie and Zhu, Tao and Cai, Ru and Zhou, Shuping and Liang, Yong and Tang, Xiaolong},
title = {MicroRNA Let‐7b‐5p Targets IGF1R to Inhibit the Progression of Hepatocellular Carcinoma Through the AKT / mTOR Pathway},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71000}
}
EUVIMED